Is it time to say goodbye to weekly rituximab in ANCA vasculitis?

被引：0
|
作者：
Pinto, Benzeeta [1 ]
Dhooria, Aadhaar [2 ]
机构：
[1] St Johns Med Coll, Dept Clin Immunol & Rheumatol, Sarjapur Rd, Bengaluru 560034, India
[2] Santokba Durlabhji Mem Hosp, Dept Clin Immunol & Rheumatol, Jaipur, Rajasthan, India
来源：
CLINICAL RHEUMATOLOGY | 2020年 / 39卷 / 10期
关键词：
CYCLOPHOSPHAMIDE;
D O I：
10.1007/s10067-020-05360-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3153 / 3154
页数：2
相关论文
共 50 条
  • [21] Infections in ANCA-associated vasculitis and lupus nephritis treated with rituximab
    Temiz, Sultan Gozde
    Barutcu Atas, Dilek
    Alibaz Oner, Fatma
    Velioglu, Arzu
    Hakki Arikan, Izzet
    Tuglular, Zubeyde Serhan
    Direskeneli, Rafi Haner
    Asicioglu, Ebru
    MARMARA MEDICAL JOURNAL, 2024, 37 (03): : 268 - 273
  • [22] Severe infections in patients with ANCA-associated vasculitis treated with rituximab
    Segelmark, Leo
    Flores-Suarez, Luis
    Mohammad, Aladdin
    RHEUMATOLOGY, 2022, 61 (01) : 205 - 212
  • [23] Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
    Smith, Rona M.
    Jones, Rachel Bronwen
    Specks, Ulrich
    Bond, Simon
    Nodale, Marianna
    Aljayyousi, Reem
    Andrews, Jacqueline
    Bruchfeld, Annette
    Camilleri, Brian
    Carette, Simon
    Cheung, Chee Kay
    Derebail, Vimal
    Doulton, Tim
    Forbess, Lindsy
    Fujimoto, Shouichi
    Furuta, Shunsuke
    Gewurz-Singer, Ora
    Harper, Lorraine
    Ito-Ihara, Toshiko
    Khalidi, Nader
    Klocke, Rainer
    Koening, Curry
    Komagata, Yoshinori
    Langford, Carol
    Lanyon, Peter
    Luqmani, Raashid Ahmed
    Makino, Hirofumi
    McAlear, Carole
    Monach, Paul
    Moreland, Larry W.
    Mynard, Kim
    Nachman, Patrick
    Pagnoux, Christian
    Pearce, Fiona
    Peh, Chen Au
    Pusey, Charles
    Ranganathan, Dwarakanathan
    Rhee, Rennie L.
    Spiera, Robert
    Sreih, Antoine G.
    Tesar, Vladimir
    Walters, Giles
    Weisman, Michael H.
    Wroe, Caroline
    Merkel, Peter
    Jayne, David
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (09) : 1243 - 1249
  • [24] PReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis
    G Mestrallet
    A Faye
    P Quartier
    B Ranchin
    P Cochat
    A Belot
    Pediatric Rheumatology, 11 (Suppl 2)
  • [25] Low-dose rituximab as induction therapy for ANCA-associated vasculitis
    Takakuwa, Yukiko
    Hanaoka, Hironari
    Kiyokawa, Tomofumi
    Iida, Harunobu
    Fujimoto, Hisae
    Yamasaki, Yoshioki
    Yamada, Hidehiro
    Kawahata, Kimito
    CLINICAL RHEUMATOLOGY, 2019, 38 (04) : 1217 - 1223
  • [26] Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis
    Niles, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 27 - 30
  • [27] The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis
    Okada, Masahiro
    Suemori, Koichiro
    Takagi, Daiki
    Teraoka, Masato
    Yamada, Hiroyuki
    Ishizaki, Jun
    Matsumoto, Takuya
    Hasegawa, Hitoshi
    Hato, Naohito
    AURIS NASUS LARYNX, 2019, 46 (01) : 38 - 42
  • [28] ANCA vasculitis: time for a change in treatment paradigm? Not yet
    Ntatsaki, Eleana
    Mooney, Janice
    Watts, Richard A.
    RHEUMATOLOGY, 2011, 50 (06) : 1019 - 1024
  • [29] Vasculitis treatment: Is it time to change the standard of care for ANCA-associated vasculitis?
    Hoffman, Gary S.
    PRESSE MEDICALE, 2013, 42 (04): : 643 - 650
  • [30] Treatment of Severe Renal Disease in ANCA Positive and Negative Small Vessel Vasculitis with Rituximab
    Shah, Shivani
    Hruskova, Zdenka
    Segelmark, Marten
    Morgan, Matthew D.
    Hogan, Jonathan
    Lee, Steven K.
    Dale, Jessica
    Harper, Lorraine
    Tesar, Vladimir
    Jayne, David R. W.
    Geetha, Duvuru
    AMERICAN JOURNAL OF NEPHROLOGY, 2015, 41 (4-5) : 296 - 301
12345